Cerity Partners LLC Sells 944 Shares of Encompass Health Co. (NYSE:EHC)

Cerity Partners LLC lowered its holdings in shares of Encompass Health Co. (NYSE:EHC) by 3.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 29,433 shares of the company’s stock after selling 944 shares during the period. Cerity Partners LLC’s holdings in Encompass Health were worth $1,964,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. International Assets Investment Management LLC bought a new stake in Encompass Health during the fourth quarter worth about $20,210,000. Nordea Investment Management AB boosted its stake in Encompass Health by 21.0% during the fourth quarter. Nordea Investment Management AB now owns 101,705 shares of the company’s stock worth $6,787,000 after acquiring an additional 17,684 shares in the last quarter. Oak Thistle LLC boosted its stake in Encompass Health by 19.1% during the fourth quarter. Oak Thistle LLC now owns 14,436 shares of the company’s stock worth $963,000 after acquiring an additional 2,319 shares in the last quarter. Sei Investments Co. boosted its stake in Encompass Health by 6.7% during the third quarter. Sei Investments Co. now owns 306,796 shares of the company’s stock worth $20,604,000 after acquiring an additional 19,254 shares in the last quarter. Finally, FMR LLC boosted its stake in Encompass Health by 11.6% during the third quarter. FMR LLC now owns 1,374,755 shares of the company’s stock worth $92,329,000 after acquiring an additional 142,633 shares in the last quarter. Institutional investors own 97.25% of the company’s stock.

Encompass Health Trading Up 0.8 %

NYSE:EHC opened at $79.22 on Friday. Encompass Health Co. has a 12 month low of $57.55 and a 12 month high of $83.73. The company has a 50 day simple moving average of $77.38 and a two-hundred day simple moving average of $70.31. The company has a current ratio of 1.28, a quick ratio of 1.28 and a debt-to-equity ratio of 1.19. The company has a market cap of $7.93 billion, a PE ratio of 22.83, a price-to-earnings-growth ratio of 1.48 and a beta of 0.94.

Encompass Health (NYSE:EHC) last released its quarterly earnings results on Wednesday, February 7th. The company reported $0.95 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.83 by $0.12. Encompass Health had a return on equity of 17.69% and a net margin of 7.33%. The business had revenue of $1.25 billion during the quarter, compared to the consensus estimate of $1.24 billion. Research analysts forecast that Encompass Health Co. will post 3.96 earnings per share for the current year.

Encompass Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, April 15th. Investors of record on Monday, April 1st were issued a $0.15 dividend. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.76%. The ex-dividend date of this dividend was Thursday, March 28th. Encompass Health’s payout ratio is 17.29%.

Analysts Set New Price Targets

Several research firms recently commented on EHC. Stephens reissued an “overweight” rating and set a $85.00 price objective on shares of Encompass Health in a research note on Tuesday, January 16th. Barclays lifted their target price on shares of Encompass Health from $95.00 to $101.00 and gave the stock an “overweight” rating in a report on Thursday, March 28th. Royal Bank of Canada reissued an “outperform” rating and issued a $83.00 target price on shares of Encompass Health in a report on Friday, February 9th. Mizuho upped their price target on Encompass Health from $77.00 to $82.00 and gave the company a “buy” rating in a report on Friday, February 9th. Finally, William Blair reaffirmed an “outperform” rating on shares of Encompass Health in a research report on Wednesday, February 7th. Eight analysts have rated the stock with a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Buy” and an average target price of $83.22.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.